| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83e7728f883dad72cebe6e6109283e55 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-36 |
| filingDate |
1994-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1997-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7ee5ce18d1ae30fb92a2f361eab3c9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6254a6d8637024418c03b376f273c6a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d88badcf52abd6966aa65ccd6412591c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af587044f475a6028ee4afd0b80d46c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c5de43efb1c8ed59c62e4d1d1724a8d |
| publicationDate |
1997-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2084230-C1 |
| titleOfInvention |
Method of psoriasis treatment |
| abstract |
FIELD: medicine, dermatology. SUBSTANCE: method involves the external use of the preparation prepared from pig skin (molecular mass is 1.4-15 kDa) at concentration 100-300 mcg/ml. Preparation inhibits proliferation and stimulates human keratinocytes differentiation and has water-soluble base that does not inactivate the preparation. EFFECT: elimination of by-side effects of preparation. 1 tbl |
| priorityDate |
1994-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |